FDA Approves Updated COVID-19 Vaccines for 65+ Years Old, But with Major Restrictions

Strategic Insights -

The Food and Drug Administration (FDA) has approved updated COVID-19 vaccines for the 2025-2026 respiratory disease season, but with significant limitations. According to a post by HHS Secretary Robert F. Kennedy Jr. on X, the updated shots made by Moderna, Pfizer, and Novavax are approved for individuals aged 65 years or older. However, the vaccines are only approved for children and younger adults who have at least one of dozens of conditions that increase their risk for severe disease. The new restrictions, announced by FDA officials earlier this year, have replaced universal recommendations for the shots.

Key Takeaways:

  • The FDA has approved updated COVID-19 vaccines for individuals aged 65 years or older.
  • The vaccines are only approved for children and younger adults with at least one high-risk condition, including conditions such as obesity, diabetes, and heart disease.
  • The specific vaccine approvals are: Moderna for people aged 6 months or older, Pfizer for people aged 5 years or older, and Novavax for people aged 12 years or older.
  • The CDC no longer recommends universal COVID-19 vaccination for children, but instead favors a shared clinical decision-making model between patients and providers.
  • The American Academy of Pediatrics (AAP) continues to recommend universal vaccination for all infants aged 6 to 23 months, as well as children aged 2 to 18 years in certain risk groups.
  • Amesh A. Adalja, MD, senior scholar at Johns Hopkins Center for Health Security, expressed concerns about children under the age of 2 who have no underlying medical issues but are still at high risk for COVID hospitalization.
  • Paul A. Offit, MD, director of the Vaccine Education Center at The Children's Hospital of Philadelphia, noted that thousands of children were hospitalized with COVID-19 last year, and emphasized the importance of vaccination, particularly for vulnerable populations.
  • The AAP president, Susan J. Kressly, MD, FAAP, has called the decision to limit access to the vaccines "deeply troubling" and highlighted the risk of respiratory illnesses for infants and toddlers.

Statistics:

  • 152 children died from COVID-19 last year (source: CDC data).
  • 1 in 5 children hospitalized with COVID-19 were admitted to the ICU (source: CDC data).
  • Thousands of children were hospitalized with COVID-19 last year (source: CDC data).

Sources:

  • X (HHS Secretary Robert F. Kennedy Jr.'s post)
  • FDA press release
  • American Academy of Pediatrics (AAP)
  • Centers for Disease Control and Prevention (CDC)
  • Healio (interview with Amesh A. Adalja, MD)
  • Healio (interview with Paul A. Offit, MD)